Sirt1 overexpression in the nucleus and Sirt3 overexpression in the mitochondria have been demonstrated to improve antioxidant defense enzymes and decrease proinflammatory pathways [165], providing protection against NAFLD and acting as sensors to promote PGC-1α expression. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.